Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ZEVRA THERAPEUTICS, INC. (KMPH)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  10.528.713.312.80.00.00.00.0
            Revenue growth  -63.5%115.6%3.5%     
Cost of goods sold  0.32.12.12.91.60.00.00.0
Gross profit  10.126.611.29.9-1.60.00.00.0
            Gross margin  96.7%92.8%83.9%77.1%    
Selling, general and administrative   [+]15.38.77.910.812.512.814.08.9
Research and development  19.610.28.819.441.820.620.513.9
Other operating expenses      0.0 35.5 
EBITDA   [+]-23.98.0-5.3-20.0-55.6-33.0-69.8-22.7
            EBITDA margin  -228.5%27.9%-40.2%-156.0%    
Depreciation and amortization  0.90.30.30.30.30.30.20.1
EBIT   [+]-24.87.7-5.6-20.3-55.9-33.4-69.9-22.8
            EBIT margin  -237.5%27.0%-42.2%-158.4%    
Non-recurring items   [+]17.7   0.0 -32.5 
Interest expense  0.30.24.84.95.55.85.52.7
Other income (expense), net   [+]0.5-16.0-2.40.74.8-4.326.5-29.2
Pre-tax income  -42.3-8.5-12.8-24.5-56.6-43.4-16.5-54.6
Income taxes  -0.80.00.00.0-0.10.00.00.0
            Tax rate  1.9% 0.3%0.1%0.2%0.1%0.1% 
Net income  -41.5-62.9-12.8-24.5-56.5-43.4-16.5-54.7
            Net margin  -397.2%-219.5%-96.0%-191.0%    
   
Basic EPS   [+]($1.20)($2.11)($3.21)($13.23)($3.15)($2.96)($1.13)($7.42)
Diluted EPS   [+]($1.20)($2.11)($3.21)($13.23)($3.15)($2.96)($1.13)($7.42)
   
Shares outstanding (basic)   [+]34.529.84.01.917.914.714.67.4
Shares outstanding (diluted)   [+]34.529.84.01.917.914.714.67.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy